Article ID Journal Published Year Pages File Type
8541684 Journal of Pharmacy Research 2013 6 Pages PDF
Abstract
Results of this study indicates that Elores is more safe and effective regimen in treating ESBL producing gram-negative and gram-positive pathogens in comparison to plain ceftriaxone.
Keywords
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology, Toxicology and Pharmaceutics (General)
Preview
Clinical, microbial efficacy and tolerability of Elores, a novel antibiotic adjuvant entity in ESBL producing pathogens: Prospective randomized controlled clinical trial
Authors
, ,